paper-with-me

Papers

Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction

2022-08-09 · David Joon Ho, Narasimhan P. Agaram, Marc-Henri Jean, Stephanie D. Suser, Cynthia Chu, Chad M. Vanderbilt, Paul A. Meyers, Leonard H. Wexler, John H. Healey, Thomas J. Fuchs, Meera R. Hameed

Osteosarcoma is the most common primary bone cancer whose standard treatment includes pre-operative chemotherapy followed by resection. Chemotherapy response is used for predicting prognosis and further management of patients. Necrosis is routinely assessed post-chemotherapy from histology slides on resection specimens where necrosis ratio is defined as the ratio of necrotic tumor to overall tumor. Patients with necrosis ratio >=90% are known to have better outcome. Manual microscopic review of necrosis ratio from multiple glass slides is semi-quantitative and can have intra- and inter-observer variability. We propose an objective and reproducible deep learning-based approach to estimate necrosis ratio with outcome prediction from scanned hematoxylin and eosin whole slide images. We collected 103 osteosarcoma cases with 3134 WSIs to train our deep learning model, to validate necrosis ratio assessment, and to evaluate outcome prediction. We trained Deep Multi-Magnification Network to segment multiple tissue subtypes including viable tumor and necrotic tumor in pixel-level and to calculate case-level necrosis ratio from multiple WSIs. We showed necrosis ratio estimated by our segmentation model highly correlates with necrosis ratio from pathology reports manually assessed by experts where mean absolute differences for Grades IV (100%), III (>=90%), and II (>=50% and <90%) necrosis response are 4.4%, 4.5%, and 17.8%, respectively. We successfully stratified patients to predict overall survival with p=10^-6 and progression-free survival with p=0.012. Our reproducible approach without variability enabled us to tune cutoff thresholds, specifically for our model and our data set, to 80% for OS and 60% for PFS. Our study indicates deep learning can support pathologists as an objective tool to analyze osteosarcoma from histology for assessing treatment response and predicting patient outcome.

📄 PDF Abstract BibTeX arXiv:2208.04910

Code (1)

mskcc-computational-pathology/dmmn-osteosarcoma 공식 구현 pytorch

Tasks

ManagementPrognosiswhole slide images

Similar Papers 제목 키워드 기반

Deep Interactive Learning: An Efficient Labeling Approach for Deep Learning-Based Osteosarcoma Treatment Response Assessment

2020-07-02 · David Joon Ho, Narasimhan P. Agaram, Peter J. Schueffler, Chad M. Vanderbilt 외

Osteosarcoma is the most common malignant primary bone tumor. Standard treatment includes pre-operative chemotherapy followed by surgical resection. The response to treatment as measured by ratio of necrotic tumor area t…

whole slide images

Bridging Classification and Segmentation in Osteosarcoma Assessment via Foundation and Discrete Diffusion Models

2025-01-03 · Manh Duong Nguyen, Dac Thai Nguyen, Trung Viet Nguyen, Homi Yamada 외

Osteosarcoma, the most common primary bone cancer, often requires accurate necrosis assessment from whole slide images (WSIs) for effective treatment planning and prognosis. However, manual assessments are subjective and…

PrognosisSegmentationwhole slide images

Radiomics-Integrated Deep Learning with Hierarchical Loss for Osteosarcoma Histology Classification

2026-01-14 · Yaxi Chen, Zi Ye, Shaheer U. Saeed, Oliver Yu 외 arxiv

Osteosarcoma (OS) is an aggressive primary bone malignancy. Accurate histopathological assessment of viable versus non-viable tumor regions after neoadjuvant chemotherapy is critical for prognosis and treatment planning,…

Binary Classification

From Human Mesenchymal Stromal Cells to Osteosarcoma Cells Classification by Deep Learning

2020-08-04 · Mario D'Acunto, Massimo Martinelli, Davide Moroni

Early diagnosis of cancer often allows for a more vast choice of therapy opportunities. After a cancer diagnosis, staging provides essential information about the extent of disease in the body and the expected response t…

Cell DetectionData AugmentationGeneral Classification

Automated Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy from DWI Data

2024-04-07 · Shir Nitzan, Maya Gilad, Moti Freiman

Effective surgical planning for breast cancer hinges on accurately predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC). Diffusion-weighted MRI (DWI) and machine learning offer a non-invasive…

Image SegmentationSegmentationSemantic SegmentationTumor Segmentation